As of 1:17pm ET
| +0.60 / +2.42%|
The 10 analysts offering 12-month price forecasts for Zealand Pharma A/S have a median target of 28.27, with a high estimate of 34.80 and a low estimate of 24.87. The median estimate represents a +11.12% increase from the last price of 25.44.
The current consensus among 10 polled investment analysts is to Buy stock in Zealand Pharma A/S. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.